Comprehensive CBD and THC metabolite panel from DBS by LC-MS/MS. Evaluation of hemp preparation efficacy.
This panel measures CBD and its metabolites alongside THC compounds, enabling evaluation of the efficacy and composition of consumed hemp preparations.
Clinical indications include:
CBD, CBD-OH (7-hydroxy-CBD), CBD-COOH (7-carboxy-CBD), THC, THC-OH (11-hydroxy-THC), THC-COOH.
All six analytes are quantified simultaneously by LC-MS/MS from a single DBS, providing a complete picture of both CBD and THC metabolism following hemp product consumption.
Cbd Panel is an important biomarker for evaluation of cbd supplementation efficacy. Masdiag measures cbd panel using validated analytical methods to provide clinically actionable results.
Cbd Panel testing is valuable for Evaluation of CBD supplementation efficacy, Assessment of THC co-exposure from hemp products. Understanding cbd panel levels helps inform personalized health optimization and clinical decision-making.
Cbd Panel collection is simple and convenient: prick your finger at home to collect a dried blood spot (DBS). This allows remote sampling without venepuncture.
This test is recommended for individuals interested in evaluation of cbd supplementation efficacy. Masdiag cbd panel testing helps guide personalized supplementation and health optimization strategies based on objective biomarker data.
Cbd Panel results provide insight into your metabolic status and evaluation of cbd supplementation efficacy. Combined with clinical context, Masdiag results inform evidence-based interventions for personalized health optimization.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.